Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoid Syndrome”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03453489
What this trial is testing

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Who this might be right for
Carcinoid SyndromeMetastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00131911
What this trial is testing

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+7 more
National Cancer Institute (NCI) 93
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Testing effectiveness (Phase 2)Study completedNCT00075439
What this trial is testing

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
National Cancer Institute (NCI) 90
Early research (Phase 1)Study completedNCT01048892
What this trial is testing

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Who this might be right for
Adrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more
Children's Oncology Group 22
Testing effectiveness (Phase 2)Ended earlyNCT00466856
What this trial is testing

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Who this might be right for
Head and Neck CancerIslet Cell TumorMetastatic Cancer+1 more
Vanderbilt-Ingram Cancer Center 10
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Not applicableLooking for participantsNCT05756608
What this trial is testing

Fibrosis in Chronic and Delayed Myocardial Infarction

Who this might be right for
Aortic StenosisChemotherapy Induced Systolic DysfunctionCarcinoid Syndrome
University of Edinburgh 180
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT00314925
What this trial is testing

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

Who this might be right for
CarcinoidNeuroendocrine
Neotropix 60
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Not applicableActive Not RecruitingNCT03498040
What this trial is testing

Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors

Who this might be right for
Carcinoid Heart Disease
Hospices Civils de Lyon 670
Not applicableStudy completedNCT01234168
What this trial is testing

Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Who this might be right for
Neuroendocrine TumorsCarcinoid Syndrome
Ipsen 340
Testing effectiveness (Phase 2)Study completedNCT00027638
What this trial is testing

Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02299089
What this trial is testing

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Who this might be right for
AcromegalyNeuroendocrine Tumors
Camurus AB 12
Large-scale testing (Phase 3)Study completedNCT02063659
What this trial is testing

Telotristat Etiprate for Carcinoid Syndrome Therapy

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 76
Testing effectiveness (Phase 2)Study completedNCT00853047
What this trial is testing

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 23
Load More Results